Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03574779 |
| Title | Phase 2 Multicohort Study to Evaluate the Safety and Efficacy of Novel Treatment Combinations in Patients With Recurrent Ovarian Cancer (OPAL) |
| Acronym | OPAL |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Tesaro, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | TUR | ESP | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35249 | United States | Details | |
| GSK Investigational Site | Los Angeles | California | 90095 | United States | Details | |
| GSK Investigational Site | San Francisco | California | 94109 | United States | Details | |
| GSK Investigational Site | Stanford | California | 94304 | United States | Details | |
| GSK Investigational Site | Ventura | California | 93003 | United States | Details | |
| GSK Investigational Site | Miami | Florida | 33136 | United States | Details | |
| GSK Investigational Site | Tampa | Florida | 33606 | United States | Details | |
| GSK Investigational Site | Chicago | Illinois | 60637 | United States | Details | |
| GSK Investigational Site | Scarborough | Maine | 04074 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02114 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02215 | United States | Details | |
| GSK Investigational Site | Saint Louis | Missouri | 63141 | United States | Details | |
| GSK Investigational Site | New York | New York | 10029 | United States | Details | |
| GSK Investigational Site | Rochester | New York | 14642 | United States | Details | |
| GSK Investigational Site | Rochester | New York | 55905 | United States | Details | |
| GSK Investigational Site | Durham | North Carolina | 27710 | United States | Details | |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| GSK Investigational Site | Sioux Falls | South Dakota | 57105 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details | |
| GSK Investigational Site | Seattle | Washington | 98104 | United States | Details | |
| GSK Investigational Site | Montreal | H2X 3E4 | Canada | Details | ||
| GSK Investigational Site | Montreal | H4A 3J1 | Canada | Details | ||
| GSK Investigational Site | Ottawa | K1H 8L6 | Canada | Details | ||
| GSK Investigational Site | La CoruNa | 15006 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28027 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28033 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28050 | Spain | Details | ||
| GSK Investigational Site | Malaga | 29011 | Spain | Details | ||
| GSK Investigational Site | Pamplona | 31008 | Spain | Details | ||
| GSK Investigational Site | Adana | 01250 | Turkey | Details | ||
| GSK Investigational Site | Ankara | 06100 | Turkey | Details | ||
| GSK Investigational Site | Ankara | Turkey | Details | |||
| GSK Investigational Site | Antalya | 07059 | Turkey | Details |